A Trial to Evaluate Safety and Efficacy of RP-L401-0120 in Subjects With Infantile Malignant Osteopetrosis
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04525352 |
|
Recruitment Status :
Terminated
(Study discontinued due to feasibility.)
First Posted : August 25, 2020
Last Update Posted : July 13, 2022
|
Sponsor:
Rocket Pharmaceuticals Inc.
Collaborator:
California Institute for Regenerative Medicine (CIRM)
Information provided by (Responsible Party):
Rocket Pharmaceuticals Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | May 21, 2021 |
| Actual Study Completion Date : | May 21, 2021 |